|
|
Exchange: |
American Stock Exchange |
Security
Type: |
Common |
Shares
Out: |
24,740,000 |
Market
Cap: |
8.42(B) |
Last
Volume: |
284,263 |
Avg
Vol: |
200,574 |
52
Week Range: |
$263.97 - $365.04 |
|
Level
I Sector: |
Information Technology |
Level
II Sector: |
Electronics |
Level
III Sector: |
Scientific & Technical Instruments |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : 247 |
Guru Rank Value : 6.5 |
Guru Occurances : 4 |
|
|
|
|
|
|
|
Company Profile Bio-Rad Laboratories is a manufacturer and distributor of its own life science research and clinical diagnostics products. Co. operates in two industry segments : Life Science, which develops, manufactures, sells and services reagents, apparatus and instruments used for biological research; and Clinical Diagnostics, which develops, manufactures, sells and services automated test systems, informatics systems, test kits and quality controls for the healthcare market. Co. sells its products and services to a customer base comprised of scientific research, healthcare, education and government organizations.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
3,623 |
3,992 |
11,334 |
17,127 |
Total Sell Value |
$1,195,713 |
$1,299,736 |
$3,688,977 |
$6,154,585 |
Total People Sold |
2 |
3 |
5 |
7 |
Total Sell Transactions |
2 |
3 |
7 |
14 |
End Date |
2024-06-20 |
2024-03-19 |
2023-09-19 |
2022-09-19 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Ernst Timothy S |
EVP, General Counsel & Sec |
|
2021-09-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
500 |
1,897 |
|
- |
|
Tumolo Annette |
Executive Vice President |
|
2021-09-03 |
4 |
D |
$819.70 |
$206,564 |
D/D |
(252) |
3,687 |
|
- |
|
Tumolo Annette |
Executive Vice President |
|
2021-09-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
557 |
3,939 |
|
- |
|
Crowley Michael |
EVP, GBL Commercial Operations |
|
2021-09-03 |
4 |
D |
$819.70 |
$227,057 |
D/D |
(277) |
4,167 |
|
- |
|
Crowley Michael |
EVP, GBL Commercial Operations |
|
2021-09-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
557 |
4,444 |
|
- |
|
Schwartz Norman D |
Chairman, President, and CEO |
|
2021-09-03 |
4 |
D |
$819.70 |
$942,655 |
D/D |
(1,150) |
421,050 |
|
- |
|
Schwartz Norman D |
Chairman, President, and CEO |
|
2021-09-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,319 |
422,200 |
|
- |
|
Daskal Ilan |
EVP, Chief Financial Officer |
|
2021-09-03 |
4 |
S |
$820.06 |
$221,416 |
D/D |
(270) |
9 |
|
- |
|
Ernst Timothy S |
EVP, General Counsel & Sec |
|
2021-09-03 |
4 |
D |
$819.70 |
$181,973 |
D/D |
(222) |
1,397 |
|
- |
|
Ernst Timothy S |
EVP, General Counsel & Sec |
|
2021-09-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
464 |
1,619 |
|
- |
|
Wright Dara |
Executive Vice President |
|
2021-09-02 |
4 |
D |
$825.77 |
$123,866 |
D/D |
(150) |
611 |
|
- |
|
Wright Dara |
Executive Vice President |
|
2021-09-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
433 |
761 |
|
- |
|
Ernst Timothy S |
EVP, General Counsel & Sec |
|
2021-09-02 |
4 |
D |
$825.77 |
$103,221 |
D/D |
(125) |
1,155 |
|
- |
|
Ernst Timothy S |
EVP, General Counsel & Sec |
|
2021-09-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
361 |
1,280 |
|
- |
|
Tumolo Annette |
Executive Vice President |
|
2021-09-02 |
4 |
D |
$825.77 |
$123,866 |
D/D |
(150) |
3,382 |
|
- |
|
Tumolo Annette |
Executive Vice President |
|
2021-09-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
433 |
3,532 |
|
- |
|
Ramalingam Ajit |
SVP, Chief Accounting Officer |
|
2021-09-02 |
4 |
D |
$825.77 |
$68,539 |
D/D |
(83) |
390 |
|
- |
|
Ramalingam Ajit |
SVP, Chief Accounting Officer |
|
2021-09-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
240 |
473 |
|
- |
|
Schwartz Norman D |
Chairman, President, and CEO |
|
2021-09-02 |
4 |
D |
$825.77 |
$739,064 |
D/D |
(895) |
419,881 |
|
- |
|
Schwartz Norman D |
Chairman, President, and CEO |
|
2021-09-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,805 |
420,776 |
|
- |
|
Daskal Ilan |
EVP, Chief Financial Officer |
|
2021-09-02 |
4 |
D |
$825.77 |
$222,132 |
D/D |
(269) |
279 |
|
- |
|
Daskal Ilan |
EVP, Chief Financial Officer |
|
2021-09-02 |
4 |
OE |
$0.00 |
$283,122 |
D/D |
1,081 |
548 |
|
- |
|
Daskal Ilan |
EVP, Chief Financial Officer |
|
2021-09-02 |
4 |
S |
$828.00 |
$447,121 |
D/D |
(540) |
7 |
|
- |
|
Last Andrew J. |
EVP, Chief Operating Officer |
|
2021-09-02 |
4 |
D |
$825.77 |
$369,945 |
D/D |
(448) |
1,736 |
|
- |
|
Last Andrew J. |
EVP, Chief Operating Officer |
|
2021-09-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
902 |
2,184 |
|
- |
|
918 Records found
|
|
Page 10 of 37 |
|
|